The global in vitro diagnostics (IVD) market size was estimated at USD 51,674.4 million in 2013. Increasing incidence rate of gastrointestinal and sexually transmitted diseases coupled with growing demand for large-scale population screening, especially for cancer and to identify whether a specific treatment or medicine would work on a patient is expected to propel industry growth over the forecast period.
Browse the report: http://www.orbisresearch.com/reports/index/in-vitro-diagnostics-ivd-market-analysis-by-product-tissue-diagnostics-molecular-diagnostics-professional-diagnostics-diabetes-monitoring-and-segment-forecasts-to-2020
In vitro diagnostics market is expected to witness growth owing to advancements and innovations in the IVD technologies, which has resulted in the introduction of novel diagnostics test applications. It is found in virtually each stage of the patient care pathway and almost every healthcare setting. However, many of these tests are remotely performed making their presence and use unnoticed.
Rising geriatric population base and demand for diagnostic testing is expected to spur the in vitro diagnostics industry. Growing prevalence of diabetes has increased the IVD demand as patients suffering from diabetes regularly use IVDs to monitor the blood glucose. According to the National Diabetes Statistics Report 2014, around 9.3% of the U.S. population or 29.1 million people have diabetes and approximately 8.1 million people or 27.8% of the U.S. population suffering from diabetes are undiagnosed.
Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/274005
Various associations are operating to monitor the industry. For instance, BIVDA is an association of companies with high interest and involvement and represents distributors and manufacturers functioning in the UK.
Increasing recognition of the diagnostics role in patient care and rapidly changing healthcare environment, with growing awareness about the diseases, are expected to promote the in vitro diagnostics market over the next six years.
Growing demand for the point-of-care identification and detection of various infectious diseases such as viruses and bacteria causing lower and upper respiratory tract infections, including influenza, RSV, pneumonia, and Legionnaires’ disease, coupled with pathogens causing malaria and filariasis is one of the major drivers for the industry.
Buy the report@http://www.orbisresearch.com/contact/purchase/274005
Major Points From Table Of Contents:
Chapter 1. Executive Summary
Chapter 2. IVD Industry Outlook
Chapter 3. IVD Product Outlook
Chapter 4. IVD Regional Outlook
Chapter 5. Competitive Landscape
Chapter 6. Methodology and Scope
List of Tables
1. IVD – Industry Summary & Critical Success Factors (CSFs)
2. Global IVD Revenue
3. Global IVD Market Revenue by Region, (USD million)
4. Global IVD Market Revenue by Products, (USD million)
5. Global Tissue Diagnostics Demand
6. Global Tissue Diagnostics Demand, by Region
7. Global Molecular Diagnostics Demand
8. Global Molecular Diagnostics Demand, by Region
9. Global Professional Diagnostics Demand
10. Global Professional Diagnostics Demand, by Region
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019